4 Patents
- US121940932025Dosing Parameters for CD47 Targeting Therapies to Hematologic Malignancies
Forty Seven, LLC
0 cites - 0 cites
- 0 cites
- US117952232023Combination Therapies for Treating Myelodysplastic Syndromes and Acute Myeloid Leukemia
Forty Seven, Inc.
0 cites